Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Hasseli

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
RMD Open|October 21, 2021
TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMDAnne Constanze Regierer, Rebecca Hasseli, Martin Schäfer, et al.
Zeitschrift Fur Rheumatologie|July 1, 2021
[German registry www.Covid19-Rheuma.de : Status report after 1 year of the pandemic]Rebecca Hasseli, Alexander Pfeil, Bimba Franziska Hoyer, et al.
Frontiers in Immunology|June 26, 2020
Adipokines and Inflammation Alter the Interaction Between Rheumatoid Arthritis Synovial Fibroblasts and Endothelial CellsRebecca Hasseli, Klaus W Frommer, Maria Schwarz, et al.
Cells|October 23, 2021
NK Cell Patterns in Idiopathic Inflammatory Myopathies with Pulmonary AffectionMarc Pawlitzki, Christopher Nelke, Leoni Rolfes, et al.
RMD Open|January 22, 2021
Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseasesRebecca Hasseli, Ulf Mueller-Ladner, Bimba F Hoyer, et al.
Vaccines|February 26, 2026
Impact of the 2023/24 Influenza Vaccination on Patients with Inflammatory Rheumatic Disease in Germany: Insights from a Nationwide, Longitudinal, Self-Reported StudyKarolina Gente, Benedikt Ditz, Eike Bormann, et al.
Orphanet Journal of Rare Diseases|April 28, 2022
Small fiber involvement is independent from clinical pain in late-onset Pompe diseaseElena K Enax-Krumova, Iris Dahlhaus, Jonas Görlach, et al.
RMD Open|April 17, 2023
Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseasesRebecca Hasseli, Jutta G Richter, Bimba Franziska Hoyer, et al.
Acta Neuropathologica|May 25, 2022
Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositisCorinna Preuße, Barbara Paesler, Christopher Nelke, et al.
Frontiers in Medicine|March 21, 2024
The protective effect of tumor necrosis factor-alpha inhibitors in COVID-19 in patients with inflammatory rheumatic diseases compared to the general population-A comparison of two German registriesRebecca Hasseli, Frank Hanses, Melanie Stecher, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
RMD Open|October 21, 2021
TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMDAnne Constanze Regierer, Rebecca Hasseli, Martin Schäfer, et al.
Zeitschrift Fur Rheumatologie|July 1, 2021
[German registry www.Covid19-Rheuma.de : Status report after 1 year of the pandemic]Rebecca Hasseli, Alexander Pfeil, Bimba Franziska Hoyer, et al.
Frontiers in Immunology|June 26, 2020
Adipokines and Inflammation Alter the Interaction Between Rheumatoid Arthritis Synovial Fibroblasts and Endothelial CellsRebecca Hasseli, Klaus W Frommer, Maria Schwarz, et al.
Cells|October 23, 2021
NK Cell Patterns in Idiopathic Inflammatory Myopathies with Pulmonary AffectionMarc Pawlitzki, Christopher Nelke, Leoni Rolfes, et al.
RMD Open|January 22, 2021
Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseasesRebecca Hasseli, Ulf Mueller-Ladner, Bimba F Hoyer, et al.
Vaccines|February 26, 2026
Impact of the 2023/24 Influenza Vaccination on Patients with Inflammatory Rheumatic Disease in Germany: Insights from a Nationwide, Longitudinal, Self-Reported StudyKarolina Gente, Benedikt Ditz, Eike Bormann, et al.
Orphanet Journal of Rare Diseases|April 28, 2022
Small fiber involvement is independent from clinical pain in late-onset Pompe diseaseElena K Enax-Krumova, Iris Dahlhaus, Jonas Görlach, et al.
RMD Open|April 17, 2023
Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseasesRebecca Hasseli, Jutta G Richter, Bimba Franziska Hoyer, et al.
Acta Neuropathologica|May 25, 2022
Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositisCorinna Preuße, Barbara Paesler, Christopher Nelke, et al.
Frontiers in Medicine|March 21, 2024
The protective effect of tumor necrosis factor-alpha inhibitors in COVID-19 in patients with inflammatory rheumatic diseases compared to the general population-A comparison of two German registriesRebecca Hasseli, Frank Hanses, Melanie Stecher, et al.
Pageof 5